Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Significance of Fatty Liver Disease in Bariatric Patients

NCT03535142 is registered in ClinicalTrials.gov with Esbjerg Hospital - University Hospital of Southern Denmark as lead sponsor.

NCT NCT03535142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03535142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Significance of Fatty Liver Disease in Bariatric Patients
Lead sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Phase
Not applicable
Overall status
Recruiting
Start date
August 15, 2018
Completion date
April 1, 2038
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic encephalopathy, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, obesity, morbid